View Item 

Show simple item record

The risk of second primary tumors in head and neck cancer: A systematic review
dc.contributor.authorCoca‐pelaz, Andrés
dc.contributor.authorRodrigo, Juan P.
dc.contributor.authorSuárez, Carlos
dc.contributor.authorNixon, Iain J.
dc.contributor.authorMäkitie, Antti
dc.contributor.authorSanabria, Alvaro
dc.contributor.authorQuer, Miquel
dc.contributor.authorStrojan, Primož
dc.contributor.authorBradford, Carol R.
dc.contributor.authorKowalski, Luiz P.
dc.contributor.authorShaha, Ashok R.
dc.contributor.authorBree, Remco
dc.contributor.authorHartl, Dana M.
dc.contributor.authorRinaldo, Alessandra
dc.contributor.authorTakes, Robert P.
dc.contributor.authorFerlito, Alfio
dc.date.accessioned2020-03-17T18:28:23Z
dc.date.availableWITHHELD_13_MONTHS
dc.date.available2020-03-17T18:28:23Z
dc.date.issued2020-03
dc.identifier.citationCoca‐pelaz, Andrés ; Rodrigo, Juan P.; Suárez, Carlos ; Nixon, Iain J.; Mäkitie, Antti ; Sanabria, Alvaro; Quer, Miquel; Strojan, Primož ; Bradford, Carol R.; Kowalski, Luiz P.; Shaha, Ashok R.; Bree, Remco; Hartl, Dana M.; Rinaldo, Alessandra; Takes, Robert P.; Ferlito, Alfio (2020). "The risk of second primary tumors in head and neck cancer: A systematic review." Head & Neck 42(3): 456-466.
dc.identifier.issn1043-3074
dc.identifier.issn1097-0347
dc.identifier.urihttps://hdl.handle.net/2027.42/154305
dc.description.abstractBackgroundSecond primary tumors (SPTs) are a common cause of reduced life expectancy in patients treated for head and neck cancer (HNC). This phenomenon forms an area to be addressed during posttreatment followâ up.MethodsWe conducted a systematic review of literature following PRISMA guidelines, from 1979 to 2019, to investigate incidence of SPTs, synchronous, and metachronous, in HNC population.ResultsOur review includes data of 456â 130 patients from 61 articles. With a minimum followâ up of 22â months, mean incidence of SPTs was 13.2% (95% CI: 11.56â 14.84): 5.3% (95% CI: 4.24â 6.36) for synchronous SPTs and 9.4% (95% CI: 7.9â 10.9) for metachronous SPTs. The most frequent site for SPTs was head and neck area, followed by the lungs and esophagus.ConclusionAlthough with wide variations between studies, the rate of SPTs in HNC patients is high. Given the impact in the prognosis, we must develop strategies for the early diagnosis of SPTs.
dc.publisherJohn Wiley & Sons, Inc.
dc.subject.othersquamous cell carcinoma
dc.subject.othersynchronous
dc.subject.otherhead and neck cancer
dc.subject.othermetachronous
dc.subject.othersecond primary tumor
dc.titleThe risk of second primary tumors in head and neck cancer: A systematic review
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelOtolaryngology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/154305/1/hed26016_am.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/154305/2/hed26016.pdf
dc.identifier.doi10.1002/hed.26016
dc.identifier.sourceHead & Neck
dc.identifier.citedreferenceAlvarez Marcos CA, Llorente Pendás JL, Franco Gutiérrez V, et al. Second primary tumors in head and neck cancer. Acta Otorrinolaringol Esp. 2006; 57: 462 â 466.
dc.identifier.citedreferenceNikolaou AC, Markou CD, Petridis DG, Daniilidis IC. Second primary neoplasms in patients with laryngeal carcinoma. Laryngoscope. 2000; 110: 58 â 64.
dc.identifier.citedreferenceAlbright JT, Karpati R, Topham AK, Spiegel JR, Sataloff RT. Second malignant neoplasms in patients under 40â years of age with laryngeal cancer. Laryngoscope. 2001; 111: 563 â 567.
dc.identifier.citedreferenceRafferty MA, O’Dwyer TP. Secondary primary malignancies in head and neck squamous cell carcinoma. J Laryngol Otol. 2001; 115: 988 â 991.
dc.identifier.citedreferenceStoeckli SJ, Zimmermann R, Schmid S. Role of routine panendoscopy in cancer of the upper aerodigestive tract. Otolaryngol Head Neck Surg. 2001; 124: 208 â 212.
dc.identifier.citedreferenceSpector JG, Sessions DG, Haughey BH, et al. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx. Laryngoscope. 2001; 111: 1079 â 1087.
dc.identifier.citedreferenceHolland JM, Arsanjani A, Liem BJ, Hoffelt SC, Cohen JI, Stevens KR. Second malignancies in early stage laryngeal carcinoma patients treated with radiotherapy. J Laryngol Otol. 2002; 116: 190 â 193.
dc.identifier.citedreferenceGao X, Fisher SG, Mohideen N, Emami B. Second primary cancers in patients with laryngeal cancer: a populationâ based study. Int J Radiat Oncol Biol Phys. 2003; 56: 427 â 435.
dc.identifier.citedreferenceWarnakulasuriya KAAS, Robinson D, Evans H. Multiple primary tumours following head and neck cancer in southern England during 1961â 98. J Oral Pathol Med. 2003; 32: 443 â 449.
dc.identifier.citedreferenceHujala K, Sipilä J, Grenman R. Panendoscopy and synchronous second primary tumors in head and neck cancer patients. Eur Arch Otorhinolaryngol. 2005; 262: 17 â 20.
dc.identifier.citedreferenceSjögren EV, Snijder S, van Beekum J, Baatenburg de Jong RJ. Second malignant neoplasia in early (TISâ T1) glottic carcinoma. Head Neck. 2006; 28: 501 â 507.
dc.identifier.citedreferenceChuang Sâ C, Scelo G, Tonita JM, et al. Risk of second primary cancer among patients with head and neck cancers: a pooled analysis of 13 cancer registries. Int J Cancer. 2008; 123: 2390 â 2396.
dc.identifier.citedreferenceLópez Mollá C, Estellés Ferriol E, Carrasco Llatas M, Seijas Rosales T, Morales Suárezâ Varela M, Dalmau Galofre J. Malignant multiple neoplasms in head and neck squamous cell carcinoma. Acta Otorrinolaringol Esp. 2008; 59: 427 â 432.
dc.identifier.citedreferenceRennemo E, Zätterström U, Boysen M. Impact of second primary tumors on survival in head and neck cancer: an analysis of 2,063 cases. Laryngoscope. 2008; 118: 1350 â 1356.
dc.identifier.citedreferenceMorris LGT, Sikora AG, Hayes RB, Patel SG, Ganly I. Anatomic sites at elevated risk of second primary cancer after an index head and neck cancer. Cancer Causes Control. 2011; 22: 671 â 679.
dc.identifier.citedreferenceRodriguezâ Bruno K, Ali MJ, Wang SJ. Role of panendoscopy to identify synchronous second primary malignancies in patients with oral cavity and oropharyngeal squamous cell carcinoma. Head Neck. 2011; 33: 949 â 953.
dc.identifier.citedreferenceJégu J, Binderâ Foucard F, Borel C, Velten M. Trends over three decades of the risk of second primary cancer among patients with head and neck cancer. Oral Oncol. 2013; 49: 9 â 14.
dc.identifier.citedreferenceKrishnatreya M, Rahman T, Kataki AC, Das A, Das AK, Lahkar K. Synchronous primary cancers of the head and neck region and upper aero digestive tract: defining highâ risk patients. Indian J Cancer. 2013; 50: 322 â 326.
dc.identifier.citedreferenceTiwana MS, Hay J, Wu J, Wong F, Cheung W, Olson RA. Incidence of second metachronous head and neck cancers: populationâ based outcomes over 25â years. Laryngoscope. 2014; 124: 2287 â 2291.
dc.identifier.citedreferencePatrucco MS, Aramendi MV. Prognostic impact of second primary tumors in head and neck cancer. Eur Arch Otorhinolaryngol. 2016; 273: 1871 â 1877.
dc.identifier.citedreferenceAdeel M, Siddiqi MI. Metachronous second primary malignancy in head and neck cancer patients: is five years of followâ up sufficient? J Korean Assoc Oral Maxillofac Surg. 2018; 44: 220 â 224.
dc.identifier.citedreferenceAdjei Boakye E, Buchanan P, Hinyard L, Osazuwaâ Peters N, Schootman M, Piccirillo JF. Incidence and risk of second primary malignant neoplasm after a first head and neck squamous cell carcinoma. JAMA Otolaryngol Head Neck Surg. 2018; 144: 727 â 737.
dc.identifier.citedreferenceLeoncini E, Vukovic V, Cadoni G, et al. Tumour stage and gender predict recurrence and second primary malignancies in head and neck cancer: a multicentre study within the INHANCE consortium. Eur J Epidemiol. 2018; 33: 1205 â 1218.
dc.identifier.citedreferenceSilén S, Haapaniemi A, Dickinson A, Rönn K, Mäkitie A. Presentation of second primary cancers in young laryngeal carcinoma patients. Acta Otolaryngol. 2019; 139: 85 â 89.
dc.identifier.citedreferenceHall SF, Groome PA, Rothwell D. The impact of comorbidity on the survival of patients with squamous cell carcinoma of the head and neck. Head Neck. 2000; 22: 317 â 322.
dc.identifier.citedreferenceWarren S, Gates O. Multiple malignant tumors: a survey of literature and statistical study. Am J Cancer. 1932; 16: 1358 â 1414.
dc.identifier.citedreferencePriante AVM, Gross JL, Sztokfisz CZ, Nishimoto IN, Kowalski LP. Diagnosis of second primary tumor and longâ term survival after single initial triple endoscopy in patients with head and neck cancer. Eur Arch Otorhinolaryngol. 2014; 271: 2285 â 2292.
dc.identifier.citedreferenceTirelli G, Piovesana M, Bonini P, Gatto A, Azzarello G, Boscolo Nata F. Followâ up of oral and oropharyngeal cancer using narrowâ band imaging and highâ definition television with rigid endoscope to obtain an early diagnosis of second primary tumors: a prospective study. Eur Arch Otorhinolaryngol. 2017; 274: 2529 â 2536.
dc.identifier.citedreferenceWang Câ H, Lee Yâ C, Wang Câ P, et al. Use of transnasal endoscopy for screening of esophageal squamous cell carcinoma in highâ risk patients: yield rate, completion rate, and safety. Dig Endosc. 2014; 26: 24 â 31.
dc.identifier.citedreferenceBugter O, van de Ven SEM, Hardillo JA, Bruno MJ, Koch AD, Baatenburg de Jong RJ. Early detection of esophageal second primary tumors using Lugol chromoendoscopy in patients with head and neck cancer: a systematic review and metaâ analysis. Head Neck. 2019; 41: 1122 â 1130.
dc.identifier.citedreferenceArantes LMRB, De Carvalho AC, Melendez ME, Lopes Carvalho A. Serum, plasma and saliva biomarkers for head and neck cancer. Expert Rev Mol Diagn. 2018; 18: 85 â 112.
dc.identifier.citedreferenceWang X, Kaczorâ Urbanowicz KE, Wong DTW. Salivary biomarkers in cancer detection. Med Oncol. 2017; 34: 7.
dc.identifier.citedreferenceHaughey BH, Gates GA, Arfken CL, Harvey J. Metaâ analysis of second malignant tumors in head and neck cancer: the case for an endoscopic screening protocol. Ann Otol Rhinol Laryngol. 1992; 101: 105 â 112.
dc.identifier.citedreferencevan der Waal I, de Bree R. Second primary tumours in oral cancer. Oral Oncol. 2010; 46: 426 â 428.
dc.identifier.citedreferenceStrojan P, Corry J, Eisbruch A, et al. Recurrent and second primary squamous cell carcinoma of the head and neck: when and how to reirradiate. Head Neck. 2015; 37: 134 â 150.
dc.identifier.citedreferenceWeichert KA, Schumrick D. Multiple malignancies in patients with primary carcinomas of the head and neck. Laryngoscope. 1979; 89: 988 â 991.
dc.identifier.citedreferenceVrabec DP. Multiple primary malignancies of the upper aerodigestive system. Ann Otol Rhinol Laryngol. 1979; 88: 846 â 854.
dc.identifier.citedreferenceGluckman JL. Synchronous multiple primary lesions of the upper aerodigestive system. Arch Otolaryngol. 1979; 105: 597 â 598.
dc.identifier.citedreferenceGrégoire V, Lefebvre Jâ L, Licitra L, Felip E, EHNSâ ESMOâ ESTRO Guidelines Working Group. Squamous cell carcinoma of the head and neck: EHNSâ ESMOâ ESTRO Clinical Practice Guidelines for diagnosis, treatment and followâ up. Ann Oncol Off J Eur Soc Med Oncol. 2010; 21: 184 â 186.
dc.identifier.citedreferenceDenaro N, Merlano MC, Russi EG. Followâ up in head and neck cancer: do more does it mean do better? A systematic review and our proposal based on our experience. Clin Exp Otorhinolaryngol. 2016; 9: 287 â 297.
dc.identifier.citedreferenceFranco EL, Kowalski LP, Kanda JL. Risk factors for second cancers of the upper respiratory and digestive systems: a caseâ control study. J Clin Epidemiol. 1991; 44: 615 â 625.
dc.identifier.citedreferenceLippman SM, Hong WK. Second malignant tumors in head and neck squamous cell carcinoma: the overshadowing threat for patients with earlyâ stage disease. Int J Radiat Oncol Biol Phys. 1989; 17: 691 â 694.
dc.identifier.citedreferenceArgiris A, Brockstein BE, Haraf DJ, et al. Competing causes of death and second primary tumors in patients with locoregionally advanced head and neck cancer treated with chemoradiotherapy. Clin Cancer Res. 2004; 10: 1956 â 1962.
dc.identifier.citedreferenceLee DH, Roh Jâ L, Baek S, et al. Second cancer incidence, risk factor, and specific mortality in head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg. 2013; 149: 579 â 586.
dc.identifier.citedreferenceSlaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer. 1953; 6: 963 â 968.
dc.identifier.citedreferenceSturgis EM, Miller RH. Second primary malignancies in the head and neck cancer patient. Ann Otol Rhinol Laryngol. 1995; 104: 946 â 954.
dc.identifier.citedreferenceSimcock R, Simo R. Followâ up and survivorship in head and neck cancer. Clin Oncol (R Coll Radiol). 2016; 28: 451 â 458.
dc.identifier.citedreferenceRoman BR, Goldenberg D, Givi B, Education Committee of American Head and Neck Society (AHNS). AHNS seriesâ do you know your guidelines? Guideline recommended followâ up and surveillance of head and neck cancer survivors. Head Neck. 2016; 38: 168 â 174.
dc.identifier.citedreferenceLeón X, del Prado Venegas M, Orús C, López M, García J, Quer M. Influence of the persistence of tobacco and alcohol use in the appearance of second neoplasm in patients with a head and neck cancer. A caseâ control study. Cancer Causes Control. 2009; 20: 645 â 652.
dc.identifier.citedreferenceMartel M, Alemany L, Taberna M, et al. The role of HPV on the risk of second primary neoplasia in patients with oropharyngeal carcinoma. Oral Oncol. 2017; 64: 37 â 43.
dc.identifier.citedreferenceMorris LGT, Sikora AG, Patel SG, Hayes RB, Ganly I. Second primary cancers after an index head and neck cancer: subsiteâ specific trends in the era of human papillomavirusâ associated oropharyngeal cancer. J Clin Oncol. 2011; 29: 739 â 746.
dc.identifier.citedreferenceAdjei Boakye E, Buchanan P, Hinyard L, et al. Risk and outcomes for second primary human papillomavirusâ related and â unrelated head and neck malignancy. Laryngoscope. 2019; 129: 1828 â 1835.
dc.identifier.citedreferenceShamseer L, Moher D, Clarke M, et al. Preferred reporting items for systematic review and metaâ analysis protocols (PRISMAâ P) 2015: elaboration and explanation. BMJ. 2015; 350: g7647.
dc.identifier.citedreferenceWeaver A, Fleming SM, Knechtges TC, Smith D. Triple endoscopy: a neglected essential in head and neck cancer. Surgery. 1979; 86: 493 â 496.
dc.identifier.citedreferenceShapshay SM, Hong WK, Fried MP, Sismanis A, Vaughan CW, Strong MS. Simultaneous carcinomas of the esophagus and upper aerodigestive tract. Otolaryngol Head Neck Surg. 1980; 88: 373 â 377.
dc.identifier.citedreferenceMaisel RH, Vermeersch H. Panendoscopy for second primaries in head and neck cancer. Ann Otol Rhinol Laryngol. 1981; 90: 460 â 464.
dc.identifier.citedreferenceAtkinson D, Fleming S, Weaver A. Triple endoscopy. A valuable procedure in head and neck surgery. Am J Surg. 1982; 144: 416 â 419.
dc.identifier.citedreferenceDeviri E, Bartal A, Goldsher M, Eliachar I, Steinitz R, Robinson E. Occurrence of additional primary neoplasms in patients with laryngeal carcinoma in Israel (1960â 1976). Ann Otol Rhinol Laryngol. 1982; 91: 261 â 265.
dc.identifier.citedreferenceMcGuirt WF. Panendoscopy as a screening examination for simultaneous primary tumors in head and neck cancer: a prospective sequential study and review of the literature. Laryngoscope. 1982; 92: 569 â 576.
dc.identifier.citedreferenceBlack RJ, Gluckman JL, Shumrick DA. Multiple primary tumours of the upper aerodigestive tract. Clin Otolaryngol Allied Sci. 1983; 8: 277 â 281.
dc.identifier.citedreferenceGrossman TW, Toohill RJ, Lehman RH, Duncavage JA, Malin TC. Role of esophagoscopy in the evaluation of patients with head and neck carcinoma. Ann Otol Rhinol Laryngol. 1983; 92: 369 â 372.
dc.identifier.citedreferenceHordijk GJ, de Jong JM. Synchronous and metachronous tumours in patients with head and neck cancer. J Laryngol Otol. 1983; 97: 619 â 621.
dc.identifier.citedreferenceAtkins JP, Keane WM, Young KA, Rowe LD. Value of panendoscopy in determination of second primary cancer. A study of 451 cases of head and neck cancer. Arch Otolaryngol. 1984; 110: 533 â 534.
dc.identifier.citedreferenceLeipzig B, Zellmer JE, Klug D. The role of endoscopy in evaluating patients with head and neck cancer. A multiâ institutional prospective study. Arch Otolaryngol. 1985; 111: 589 â 594.
dc.identifier.citedreferencede Vries N, Van der Waal I, Snow GB. Multiple primary tumours in oral cancer. Int J Oral Maxillofac Surg. 1986; 15: 85 â 87.
dc.identifier.citedreferenceLau WF, Siu KF, Wei W, Lam KH. Prospective screening for multiple tumors of the upper aerodigestive tract: a simple routine procedure. Laryngoscope. 1986; 96: 1149 â 1153.
dc.identifier.citedreferenceLundgren J, Olofsson J. Multiple primary malignancies in patients treated for laryngeal carcinoma. J Otolaryngol. 1986; 15: 145 â 150.
dc.identifier.citedreferenceSchuller DE, Fritsch MH. An assessment of the value of triple endoscopy in the evaluation of head and neck cancer patients. J Surg Oncol. 1986; 32: 156 â 158.
dc.identifier.citedreferenceShikhani AH, Matanoski GM, Jones MM, Kashima HK, Johns ME. Multiple primary malignancies in head and neck cancer. Arch Otolaryngol Head Neck Surg. 1986; 112: 1172 â 1179.
dc.identifier.citedreferenceShibuya H, Hisamitsu S, Shioiri S, Horiuchi J, Suzuki S. Multiple primary cancer risk in patients with squamous cell carcinoma of the oral cavity. Cancer. 1987; 60: 3083 â 3086.
dc.identifier.citedreferenceMasaki N, Hashimoto T, Ikeda H, Inoue T, Kozuka T. Multiple primary malignancies in patients with head and neck cancer. Jpn J Clin Oncol. 1987; 17: 303 â 307.
dc.identifier.citedreferencePoppendieck J. Incidence of multiple tumors in the upper aerodigestive tract. Routine panendoscopy? HNO. 1987; 35: 19 â 23.
dc.identifier.citedreferenceParker JT, Hill JH. Panendoscopy in screening for synchronous primary malignancies. Laryngoscope. 1988; 98: 147 â 149.
dc.identifier.citedreferencePoppendieck J, Schrader M. Improved diagnosis of second carcinomas by routine panendoscopy. Adv Otorhinolaryngol. 1988; 39: 111 â 119.
dc.identifier.citedreferenceShaha A, Hoover E, Marti J, Krespi Y. Is routine triple endoscopy costâ effective in head and neck cancer? Am J Surg. 1988; 155: 750 â 753.
dc.identifier.citedreferenceHordijk GJ, Bruggink T, Ravasz LA. Panendoscopy: a valuable procedure? Otolaryngol Head Neck Surg. 1989; 101: 426 â 428.
dc.identifier.citedreferencePanosetti E, Luboinski B, Mamelle G, Richard JM. Multiple synchronous and metachronous cancers of the upper aerodigestive tract: a nineâ year study. Laryngoscope. 1989; 99: 1267 â 1273.
dc.identifier.citedreferencePanosetti E, Arnold W, Müller W. Site and incidence of multiple cancers in patients with squamous cell carcinomas of the upper aerodigestive tract. Laryngorhinootologie. 1990; 69: 449 â 453.
dc.identifier.citedreferenceChoy AT, van Hasselt CA, Chisholm EM, Williams SR, King WW, Li AK. Multiple primary cancers in Hong Kong Chinese patients with squamous cell cancer of the head or neck. Cancer. 1992; 70: 815 â 820.
dc.identifier.citedreferenceEsteller Moré E, Quer Agusti M, Burgues Vila J, Viladot Castells J, Lópezâ Pousa A, Vega M. Synchronous carcinomas of the upper aerodigestive tract: a diagnostic and therapeutic problem. Acta Otorrinolaringol Esp. 1992; 43: 329 â 334.
dc.identifier.citedreferenceSchwartz LH, Ozsahin M, Zhang GN, et al. Synchronous and metachronous head and neck carcinomas. Cancer. 1994; 74: 1933 â 1938.
dc.identifier.citedreferenceJones AS, Morar P, Phillips DE, Field JK, Husband D, Helliwell TR. Second primary tumors in patients with head and neck squamous cell carcinoma. Cancer. 1995; 75: 1343 â 1353.
dc.identifier.citedreferenceDhooge IJ, De Vos M, Albers FW, Van Cauwenberge PB. Panendoscopy as a screening procedure for simultaneous primary tumors in head and neck cancer. Eur Arch Otorhinolaryngol. 1996; 253: 319 â 324.
dc.identifier.citedreferenceLeón X, Quer M, Diez S, Orús C, Lópezâ Pousa A, Burgués J. Second neoplasm in patients with head and neck cancer. Head Neck. 1999; 21: 204 â 210.
dc.identifier.citedreferenceEsposito ED, Bevilacqua L, Guadagno MT. Multiple primary malignant neoplasm in patients with laryngeal carcinoma. J Surg Oncol. 2000; 74: 83 â 86.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
hed26016_am.pdf
Size:
279.6KB
Format:
PDF
View/Open
Name:
hed26016.pdf
Size:
1.025MB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.